2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Rehabilitation: Physical therapy, occupational therapy, and return to work programs.
Rehabilitation in cancer care plays a key role in supporting patients’ recovery after treatment, particularly through physical therapy, occupational therapy, and return-to-work programs. Cancer treatments, such as surgery, chemotherapy, and radiation, can cause long-lasting physical impairments, ranging from reduced mobility and strength to sensory changes. Physical therapy helps patients regain mobility, strength, and endurance, while occupational therapy focuses on improving daily functioning, such as dressing, cooking, and managing household tasks. Additionally, for those who were employed prior to their diagnosis, return-to-work programs are essential in easing the transition back into the workforce. These programs help cancer survivors manage their physical and emotional well-being while navigating the challenges of rejoining the workforce. A comprehensive rehabilitation plan tailored to the patient’s needs can significantly enhance their independence, emotional well-being, and overall quality of life, making it an essential aspect of post-treatment cancer care.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China